Insights on Genitourinary Tuberculosis: Prevalence and Management Strategies

May 15, 2025

10 likes | 94 Views

This study explores the prevalence of tuberculosis, including extra-pulmonary and genitourinary cases, and provides insights into the etiology and management strategies. It delves into the challenges and approaches for tackling genitourinary tuberculosis.

Share Presentation

Embed Code

gino

Download Presentation

Insights on Genitourinary Tuberculosis: Prevalence and Management Strategies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Table 1 Studies demonstrating the prevalence of TB, EPTB and GUTB Abbara, A. & Davidson, R. N. (2011) Etiology and management of genitourinary tuberculosis Nat. Rev. Urol. doi:10.1038/nrurol.2011.172

Pediatric TB and HIV The Potential of New TB Vaccines

Pediatric TB and HIV The Potential of New TB Vaccines. Dr. Hoosen Coovadia Nelson Mandela School of Medicine, University of KwaZulu Natal Board of Directors, Aeras Global TB Vaccine Foundation Presentation to the CORE Group May 17, 2010. Estimated TB Incidence Rate, 2007.

503 views • 27 slides

HIV/TB – Case Studies

HIV/TB – Case Studies. David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health. Case # 1. A 23 year-old African-American man presents with a 3-week history of fever, cough and 15 pound weight loss. He admits to IVDA. Physical exam

478 views • 17 slides

PREVALENCE OF MDR-TB AMONGST PATIENTS WITH HIV AND TB CO-INFECTION SEEN AT THE DOTS CLINIC OF N.I.M.R., LAGOS, NIGERIA.

OUTLINE. BackgroundAim of studyObjectivesMethodologyResultsDiscussionConclusionsRecommendations. BACKGROUND . The global HIV infection epidemic has caused explosive increases in MDR-TB{ Mycobacterium tuberculosis strain developing resistant to both RIF and INH} (Wells et al, 2007)Estimated

357 views • 14 slides

The Prevalence of Dementia

The Prevalence of Dementia. 1991 Baseline Study. CSHA Study Centres. 1000 kms . Prevalence of Dementia Canada 1991-92. Rate per 1,000. Source: Can Med Assoc J 1994;150:899-913. Estimated Numbers of Canadians, 65+, with Dementia, 1991. Source: Can Med Assoc J 1994;150:899-913.

212 views • 8 slides

Partner carers: prevalence and characteristics (1)

‘In sickness and in health’ and beyond: reconciling work and care for a partner in england August 13 th 2013 Dr Gary Fry Research Fellow CIRCLE Centre for International Research on Care, Labour and Equalities University of Leeds, UK. Partner carers: prevalence and characteristics (1).

230 views • 9 slides

Assignment 1 Presentation Demonstrating the use of;

EDIT. Assignment 1 Presentation Demonstrating the use of;. -Microsoft Powerpoint. -Image Management Software. -Microsoft Movie Maker. For Primary Students. Image Manipulation. Below is an image that I have chosen to manipulate through a number steps,.

235 views • 11 slides

Demonstrating the Use of PowerPoint

Demonstrating the Use of PowerPoint. Designed to accompany pages 110-114 of the textbook by Dr. John A. Kline’s Speaking Effectively or the July and August 2003 Columns at : www.klinespeak.com.

309 views • 15 slides

TB and HIV Management in High HIV Prevalence Settings: the Policy Perspective

TB and HIV Management in High HIV Prevalence Settings: the Policy Perspective. Kevin M. De Cock Center for Global Health Centers for Disease Control and Prevention. Integration Blues. Why integrate? Improved health outcomes Better service performance Increased efficiency Cost savings

300 views • 18 slides

Table 1. Demographics of the subjects

92 views • 1 slides

Table 3 Studies investigating the affected organs and symptoms in women with GUTB

Table 3 Studies investigating the affected organs and symptoms in women with GUTB. Abbara, A. & Davidson, R. N. (2011) Etiology and management of genitourinary tuberculosis Nat. Rev. Urol. doi:10.1038/nrurol.2011.172.

96 views • 1 slides

Table 2 Studies investigating the symptoms of GUTB*

Table 2 Studies investigating the symptoms of GUTB*. Abbara, A. & Davidson, R. N. (2011) Etiology and management of genitourinary tuberculosis Nat. Rev. Urol. doi:10.1038/nrurol.2011.172.

125 views • 1 slides

Demonstrating the Outcomes

What Does it Take to Make a Difference?. Demonstrating the Outcomes. Joint PDI / STRADA MASTERCLASS. Purpose of Today. “PDI has made a significant contribution to the voluntary sector’s response to the needs of children and young people in the context of family and

291 views • 14 slides

Table 1 LUTO subtypes and associated anomalies with total prevalence

Table 1 LUTO subtypes and associated anomalies with total prevalence. Kilby, M. D. & Morris, R. K. (2014) Fetal therapy for the treatment of congenital bladder neck obstruction Nat. Rev. Urol. doi:10.1038/nrurol.2014.132.

156 views • 1 slides

Studies of W’  tb  Wbb  lvbb

Studies of W’  tb  Wbb  lvbb. Why W' important?. Many beyond-the-standard model theories have predicted W' Extra-dimension model Theories that have an extra SU(2) gauge group Right-handed W boson Technicolor theory Little higgs theory Main decay channels: W' -> e/mu + neutrino

197 views • 11 slides

1. Prevalence of school violence

Resources of Secondary Teachers’ Resilience Facing School Violence in Romania and Quebec Viorica Tudor- Dobrica & Manon Théorêt University of Montreal, Québec-Canada viorica.dobrica@umontreal.ca.

417 views • 20 slides

TB and Drug Resistant TB Case Studies

TB and Drug Resistant TB Case Studies. Philip W. Smith, MD Chief, Infectious Diseases University of Nebraska Medical Canter. Reported TB Cases United States, 1953 - 1998. 100,000. 70,000. *. 50,000. Cases (Log Scale). *. 30,000. 20,000. 10,000. 53. 60. 70. 80. 90. 98. Year.

523 views • 32 slides

Table 1 Summary of studies of primary BAD diagnosed by SeHCAT

Table 1 Summary of studies of primary BAD diagnosed by SeHCAT. Walters, J. R. F. (2014) Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2014.32.

128 views • 1 slides

Observational Epidemiologic Studies Descriptive (incidence, prevalence)

Study type 1. Observational Epidemiologic Studies Descriptive (incidence, prevalence) Analytic (associate characteristics of population with risk of disease). Study type 2. Epidemiology - Design and Bias Evaluation Spring 2005. Reference: Szklo M and Nieto FJ. Epidemiology – Beyond the

2.07k views • 185 slides

Table 1 General characteristics of glycosylation studies in IBD

Table 1 General characteristics of glycosylation studies in IBD. Theodoratou, E. et al. (2014) The role of glycosylation in IBD Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2014.78.

107 views • 1 slides

Table 1 Microparticles as biomarkers of rheumatic diseases: clinical studies and findings

Table 1 Microparticles as biomarkers of rheumatic diseases: clinical studies and findings. Beyer, C. & Pisetsky, D. S. (2009) T he role of microparticles in the pathogenesis of rheumatic diseases Nat. Rev. Rheumatol . doi:10.1038/nrrheum.2009.229.

130 views • 1 slides

Table 1 Impact of prevalence on predictive values

Table 1 Impact of prevalence on predictive values. Lo, D. J. et al. (2014) Biomarkers for kidney transplant rejection Nat. Rev. Nephrol. doi:10.1038/nrneph.2013.281.

80 views • 1 slides

Understanding and Demonstrating the benefits of improvement

Understanding and Demonstrating the benefits of improvement. A work in progress!. Where do you begin?. Quality improvement for the service user Increase percentage of patients receiving this surgery as a day case from 22% to 50% by April 2010 What difference does this make for patients?.

137 views • 12 slides

More Related